IMM PE buys stake in Hanssem Korea furniture company
Jul 15, 2021 07:48 am UTC| Business Economy
IMM Private Equity is said to be in talks to buy a stake in Hanssem, South Koreas largest interior and furniture company. Based on the reports, the PE firm signed a memorandum of understanding (MOU) with Hanssem to acquire...
Hewlett Packard Enterprise, HanmiGlobal ink partnership deal to open data centers in S. Korea
Jul 15, 2021 06:51 am UTC| Business Economy
Hewlett Packard Enterprise and HanmiGlobal have joined forces to make South Korea Asias next data center hub. The Texas-based information technology company and the Korean construction project management firm have agreed...
Facebook, Instagram: Mark Zuckerberg investing $1 billion to pay content creators
Jul 15, 2021 06:09 am UTC| Business Economy
Facebook is investing $1 billion to compensate content creators on FB and Instagram. The good news was personally announced by the companys chief executive officer, Mark Zuckerberg, on Wednesday, July 14. We want to...
Coke tweaks recipe for its popular beverage to offer a fuller taste
Jul 14, 2021 10:01 am UTC| Business Economy
Coke just updated its recipe for its Coca-Cola Zero Sugar beverage variant as it wants customers to enjoy the full taste of a regular Coke. The companys no-sugar versions of Coke surely taste a bit different since it does...
Burger King Malaysia launches head-turning new Chocolate Melt Beefacon burger
Jul 14, 2021 09:50 am UTC| Business Economy
Burger King Malaysia surely turn heads when it announced the launch of its two new sandwiches. This is because both menu items were drenched in chocolate! The new chocolatey sandwiches at BK Burger King Malaysia...
Mamamoo’s agency, Rainbowbridge World, announces plans to go public
Jul 14, 2021 09:39 am UTC| Business Economy
Rainbowbridge World, the entertainment agency that manages the popular Kpop girl group, Mamamoo, just unveiled its plans to go public before this year ends. The company will start with South Koreas secondary bourse first,...
Celltrion’s final trial for its COVID-19 drug shows it can lower risk of severe infection by 70%
Jul 14, 2021 08:26 am UTC| Business Economy
Celltrion revealed the results of its phase 3 clinical trial for its COVID-19 treatment drug called Regkirona. The final testing was said to have yielded good results, and the biopharmaceutical company headquartered in...
South Africa’s plan to move away from coal: 8 steps to make it succeed
Germany lowers voting age to 16 for the European elections
IceCube researchers detect a rare type of energetic neutrino sent from powerful astronomical objects